Vaccines are important for protecting individuals at increased risk of severe infections,
including patients undergoing DMARD therapy. However, DMARD therapy can also …

There is increased interest related to the impact of coronavirus disease 19 (COVID-19) on
the endocrine system and in particular on the pituitary gland. Over the course of the severe …

Objective To estimate the prevalence of patients with an immunocompromising condition at
risk for COVID-19, estimate COVID-19 prevalence rate (PR) and incidence rate (IR) by …

Background Humoral and cellular immune responses are known to be crucial for patients to
recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected …

Background A well-coordinated adaptive immune response is crucial for limiting COVID-19
disease. Some individuals with immunodeficiency are at a high risk of developing severe …

Patients with autoimmune diseases are among the susceptible groups to COVID-19
infection because of the complexity of their conditions and the side effects of the …

Background Patients with autoimmune rheumatic diseases (ARD) are at a potentially higher
risk for COVID-19 infection complications. Given their inherent altered immune system and …

Joint pain and arthralgia can be manifestations of COVID-19, and studies evaluating long
COVID symptoms identified the persistence of these disorders. Moreover, some case reports …

Vaccination is the best way to limit the extent of the COVID pandemic. Knowledge of the
duration of the immune response will allow the planning of a vaccination protocol. This study …

Introduction The coronavirus disease 2019 (COVID-19) pandemic impacted how people
perform their daily lives in manifold and sometimes massive ways. Particularly, individuals …